Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
) (98.65) 23.42 (122.07) (521.24) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (521.23) Net Profit The company and subsidiaries realized net profit (loss) of the 1st quarter ended as of March 31
97.71 207.89 Earnings per share (Baht per share) (0.01) 0.01 (0.02) (207.89) Net Profit The company and subsidiaries realized net profit (loss) of the 2nd quarter ended as of June 30, 2017, of THB (50.71
) 120.53 597.88 Earnings per share (Baht per share) 0.02 (0.00) 0.03 597.88 Net Profit The company and subsidiaries realized net prof it of the 3rd quarter ended as of September 30, 2017, of THB 100.37
) 120.53 597.88 Earnings per share (Baht per share) 0.022 (0.004) 0.026 597.88 Net Profit The company and subsidiaries realized net profit of the 3rd quarter ended as of September 30, 2017, of THB 100.37
. Within 9 months the competitors gradually disappeared and the company gained 50% market share. In the part of mobile top-up market share, the company gained it from several channels especially ROM. As a
Profit (Loss) (72.28) 42.70 (114.98) (269.26) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (269.26) Net Profit The company and subsidiaries realized net loss of Year 2017 ended as of December 31
) Net Profit (Loss) (72.28) 42.70 (114.98) (269.26) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (269.26) Net Profit The company and subsidiaries realized net loss of Year 2017 ended as of
องทุนรวมประเภทเฮ็ดจฟนด (Hedge fund) กองทุน Morgan Stanley Investment Funds US Advantage Fund (กองทุนหลัก) แบงหนวย ลงทุนท่ีเสนอขายออกเปน Share Class ซึ่งจะแตกตางกันท่ีรายละเอียดตางๆ เชน มูลค
for the period 16,889 29,536 20,538 (3,649) (17.8) Gross profit margin 22.6% 22.6% 22.4% 0.2% - Basic earnings per share (Baht/share) 0.04 0.07 0.05 (0.01) (17.8) Net profit margin 4.0% 7.3% 5.5% -1.5